PuSH - Publikationsserver des Helmholtz Zentrums München

Klaeger, S.* ; Heinzlmeir, S.* ; Wilhelm, M.* ; Polzer, H.* ; Vick, B. ; Koenig, P.A.* ; Reinecke, M.* ; Ruprecht, B.* ; Petzoldt, S.* ; Meng, C.* ; Zecha, J.* ; Reiter, K.* ; Qiao, H.* ; Helm, D.* ; Koch, H.* ; Schoof, M.* ; Canevari, G.* ; Casale, E.* ; Depaolini, S.R.* ; Feuchtinger, A. ; Wu, Z.* ; Schmidt, T.* ; Rueckert, L.* ; Becker, W.* ; Huenges, J.* ; Garz, A.K.* ; Gohlke, B.O.* ; Zolg, D.P.* ; Kayser, G.* ; Vooder, T.* ; Preissner, R.* ; Hahne, H.* ; Tõnisson, N.* ; Kramer, K.* ; Götze, K.* ; Bassermann, F.* ; Schlegl, J.* ; Ehrlich, H.C.* ; Aiche, S.* ; Walch, A.K. ; Greif, P.A.* ; Schneider, S.* ; Felder, E.R.* ; Ruland, J.* ; Médard, G.* ; Jeremias, I. ; Spiekermann, K.* ; Kuster, B.*

The target landscape of clinical kinase drugs.

Science 358:eaan4368 (2017)
Verlagsversion Forschungsdaten DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Kinase inhibitors are important cancer therapeutics. Polypharmacology is commonly observed, requiring thorough target deconvolution to understand drug mechanism of action. Using chemical proteomics, we analyzed the target spectrum of 243 clinically evaluated kinase drugs. The data revealed previously unknown targets for established drugs, offered a perspective on the "druggable" kinome, highlighted (non)kinase off-targets, and suggested potential therapeutic applications. Integration of phosphoproteomic data refined drug-affected pathways, identified response markers, and strengthened rationale for combination treatments. We exemplify translational value by discovering SIK2 (salt-inducible kinase 2) inhibitors that modulate cytokine production in primary cells, by identifying drugs against the lung cancer survival marker MELK (maternal embryonic leucine zipper kinase), and by repurposing cabozantinib to treat FLT3-ITD-positive acute myeloid leukemia. This resource, available via the ProteomicsDB database, should facilitate basic, clinical, and drug discovery research and aid clinical decision-making.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Integrative Genomics Viewer; Salt-inducible Kinases; Chemical Proteomics; Inhibitor Selectivity; Comprehensive Analysis; Data Quality; Protein; Quantification; Refinement; Cancer
ISSN (print) / ISBN 0036-8075
e-ISSN 1095-9203
Zeitschrift Science
Quellenangaben Band: 358, Heft: 6367, Seiten: , Artikelnummer: eaan4368 Supplement: ,
Verlag American Association for the Advancement of Science (AAAS)
Verlagsort Washington
Begutachtungsstatus
Institut(e) Research Unit Apoptosis in Hematopoietic Stem Cells (AHS)
Research Unit Analytical Pathology (AAP)